Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
| Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
| Orexin Receptor Antagonist (OX1R and OX2R) | Small molecule | Neurological disease | Insomnia Disorder | Phase III | Global (except China) |
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| OX2-M82F3 | Mouse | Biotinylated Mouse CD200 / OX-2 Protein, Fc,Avitag™ (MALS verified) |  |
|
|
| OX2-H82F1 | Human | Biotinylated Human CD200 / OX-2 Protein, Fc,Avitag™ |  |
|
|
| OX2-H5228 | Human | Human CD200 / OX-2 Protein, His Tag |  |
|
|
| OX2-H5251 | Human | Human CD200 / OX-2 Protein, Fc Tag |  |
|
|
Immobilized Human CD200 R1, His Tag (Cat. No. CR2-H52H6) at 5 μg/mL (100 μL/well) can bind Biotinylated Human CD200, Fc,Avitag (Cat. No. OX2-H82F1) with a linear range of 0.2-2 ng/mL (QC tested).
The purity of Biotinylated Mouse CD200, Fc,Avitag (Cat. No. OX2-M82F3) is more than 90% and the molecular weight of this protein is around 125-135 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| P-006 | P-006; 23ME-610; 23ME-00610 | Phase 2 Clinical | 23andme Inc | Solid tumours; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Carcinoma, Ovarian Epithelial; Neuroendocrine Tumors; Peritoneal Neoplasms; Fallopian Tube Neoplasms | Details |
| CD-200-AR-L | CD-200-AR-L; hP-1-A-8 | Phase 1 Clinical | University Of Minnesota, OX2 Therapeutics | Glioblastoma; Glioma | Details |
| P-006 | P-006; 23ME-610; 23ME-00610 | Phase 2 Clinical | 23andme Inc | Solid tumours; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Carcinoma, Ovarian Epithelial; Neuroendocrine Tumors; Peritoneal Neoplasms; Fallopian Tube Neoplasms | Details |
| CD-200-AR-L | CD-200-AR-L; hP-1-A-8 | Phase 1 Clinical | University Of Minnesota, OX2 Therapeutics | Glioblastoma; Glioma | Details |
This web search service is supported by Google Inc.
A-Z
